PT Bayu Buana Tbk (IDX:BAYU)

Verve Therapeutics Cash Flow Statement

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	102,397	102,173	70,807	42,982	514.21	1,686
Depreciation & Amortization	6,121	6,121	6,329	8,004	7,100	6,082
Other Operating Activities	-88,440	46,478	12,362	-60,578	-44,528	90,031
Operating Cash Flow	20,078	154,772	89,499	-9,592	-36,914	97,798
Operating Cash Flow Growth	-84.71%	72.93%	-	-	-	37.50%
Capital Expenditures	-28,735	-15,440	-6,378	-8,880	-2,904	-3,030
Sale of Property, Plant & Equipment	564.64	564.64	461.91	318	650.4	736.7
Other Investing Activities	23,179	21,394	16,323	11,299	15,017	18,404
Investing Cash Flow	-4,992	6,518	10,407	2,738	12,764	16,111
Long-Term Debt Repaid	-	-	-390.4	-678.12	-671.37	-
Net Debt Issued (Repaid)	-	-	-390.4	-678.12	-671.37	-
Common Dividends Paid	-61,814	-26,492	-17,661	-8,831	-8,831	-17,661
Other Financing Activities	-	-	-	-	-	-685.7
Financing Cash Flow	-61,814	-26,492	-18,051	-9,509	-9,502	-18,347
Foreign Exchange Rate Adjustments	968.59	534.39	-809.14	4,707	230.91	1,269
Net Cash Flow	-45,759	135,334	81,046	-11,656	-33,420	96,831
Free Cash Flow	-8,657	139,332	83,121	-18,472	-39,817	94,768
Free Cash Flow Growth	-	67.63%	-	-	-	40.61%
Free Cash Flow Margin	-0.33%	5.39%	3.82%	-1.03%	-8.11%	17.18%
Free Cash Flow Per Share	-24.51	394.46	235.32	-52.30	-112.73	268.30
Cash Income Tax Paid	15,077	15,077	6,382	1,724	-801.55	5,462
Levered Free Cash Flow	-13,648	99,754	70,619	-18,176	-28,978	115,393
Unlevered Free Cash Flow	-13,624	99,754	70,619	-18,171	-28,969	115,406
Change in Net Working Capital	56,190	-44,270	-26,945	38,482	24,011	-123,141

Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.